Anhydrous lactose market seen rising to $1.64 billion by 2030
The global anhydrous lactose market is projected to grow from $1.24 billion in 2025 to $1.64 billion by 2030, driven by pharmaceutical manufacturing, generic drugs and demand for stable excipients. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.
Why it matters: - Anhydrous lactose is a key excipient in tablets and capsules, so market growth tracks broader pharmaceutical output. - Rising demand for stable, moisture-resistant ingredients matters most for solid oral dosage forms and sensitive formulations. - The market’s expansion reflects more generic drug production, more biopharmaceutical manufacturing and tighter excipient quality standards.
What happened: - The Business Research Company released a 2026 report on the global anhydrous lactose market. - The report estimates market value at $1.32 billion in 2026, up from $1.24 billion in 2025. - The report projects the market will reach $1.64 billion by 2030. - The report forecasts a 6.0% CAGR for 2025-2026 and a 5.6% CAGR through 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.
The details: - Anhydrous lactose is a purified form of lactose with very low moisture content. - Pharmaceutical manufacturers use it as a filler or diluent in tablets and capsules. - The ingredient helps provide consistent dosing and improve tablet strength. - Its moisture-resistant properties support stability in sensitive drug formulations. - The ingredient also improves powder flow during manufacturing. - Growth drivers listed in the report include solid oral dosage production, generic drug manufacturing, wider use of lactose-based excipients and expanded pharmaceutical capacity. - The forecast cites demand for excipients with high stability, advances in drug formulation, growth in contract manufacturing organizations and more regulatory focus on excipient traceability. - Expected trends include wider use in moisture-sensitive formulations, more demand for direct-compression grades, better powder flow properties, broader excipient applications and improved quality control in lactose production. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics and updated graphics and tables.
Between the lines: - Pharmaceutical output is the main demand signal behind the market’s growth path. - The shift toward direct-compression and moisture-sensitive formulations suggests buyers want excipients that do more than fill space. - Regional growth in Asia-Pacific likely reflects broader pharma manufacturing expansion and rising contract production activity. - Europe’s pharmaceutical production reached €390,000 million in 2023, up from €363,300 million in 2022, underscoring the manufacturing backdrop supporting excipient demand.
What's next: - Demand should keep rising as drug makers look for stable excipients that support shelf life, flow and manufacturing efficiency. - Regulatory scrutiny on traceability is likely to push suppliers toward stronger quality systems and documentation. - More contract manufacturing and biopharma production could widen the market beyond traditional tablet and capsule uses. - More information
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Science Press Releases
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.